ATAI
Price
$1.52
Change
-$0.00 (-0.00%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
305.69M
25 days until earnings call
CYBN
Price
$7.12
Change
+$0.20 (+2.89%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
144.99M
Ad is loading...

ATAI vs CYBN

Header iconATAI vs CYBN Comparison
Open Charts ATAI vs CYBNBanner chart's image
ATAI Life Sciences
Price$1.52
Change-$0.00 (-0.00%)
Volume$14.89K
Capitalization305.69M
Cybin
Price$7.12
Change+$0.20 (+2.89%)
Volume$5.3K
Capitalization144.99M
ATAI vs CYBN Comparison Chart
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. CYBN commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a StrongBuy and CYBN is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ATAI: $1.52 vs. CYBN: $6.92)
Brand notoriety: ATAI and CYBN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 104% vs. CYBN: 90%
Market capitalization -- ATAI: $293.7M vs. CYBN: $147.7M
ATAI [@Biotechnology] is valued at $293.7M. CYBN’s [@Biotechnology] market capitalization is $147.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileCYBN’s FA Score has 1 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • CYBN’s FA Score: 1 green, 4 red.
According to our system of comparison, ATAI is a better buy in the long-term than CYBN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 4 TA indicator(s) are bullish while CYBN’s TA Score has 5 bullish TA indicator(s).

  • ATAI’s TA Score: 4 bullish, 3 bearish.
  • CYBN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ATAI and CYBN are a good buy in the short-term.

Price Growth

ATAI (@Biotechnology) experienced а +7.39% price change this week, while CYBN (@Biotechnology) price change was -7.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 18, 2025.

CYBN is expected to report earnings on Nov 13, 2024.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI($306M) has a higher market cap than CYBN($145M). ATAI YTD gains are higher at: 14.662 vs. CYBN (-21.542). ATAI has higher annual earnings (EBITDA): -124.33M vs. CYBN (-134.52M). CYBN has more cash in the bank: 136M vs. ATAI (85.9M). CYBN has less debt than ATAI: CYBN (0) vs ATAI (23.8M). ATAI has higher revenues than CYBN: ATAI (331K) vs CYBN (0).
ATAICYBNATAI / CYBN
Capitalization306M145M211%
EBITDA-124.33M-134.52M92%
Gain YTD14.662-21.542-68%
P/E RatioN/AN/A-
Revenue331K0-
Total Cash85.9M136M63%
Total Debt23.8M0-
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAICYBN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 17 days ago
85%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYTTX252.17N/A
N/A
Rydex S&P 500 2x Strategy A
IYBIX22.34N/A
N/A
Macquarie Balanced Fund Class I
GLVAX71.52N/A
N/A
Invesco Global Focus A
LGLOX41.73N/A
N/A
Lord Abbett Growth Leaders F3
JHISX11.43N/A
N/A
Janus Henderson VIT Global Sust Eq Ins

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
+3.74%
MNMD - ATAI
51%
Loosely correlated
+5.00%
RXRX - ATAI
47%
Loosely correlated
-0.89%
CRSP - ATAI
47%
Loosely correlated
-1.76%
CYBN - ATAI
46%
Loosely correlated
-1.84%
ABCL - ATAI
46%
Loosely correlated
+0.79%
More

CYBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYBN has been loosely correlated with ATAI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CYBN jumps, then ATAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYBN
1D Price
Change %
CYBN100%
-1.84%
ATAI - CYBN
46%
Loosely correlated
+3.74%
ABSI - CYBN
40%
Loosely correlated
-0.47%
ABCL - CYBN
40%
Loosely correlated
+0.79%
RXRX - CYBN
35%
Loosely correlated
-0.89%
VTGN - CYBN
34%
Loosely correlated
+5.85%
More